|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/445 | |
| A61K 31/4468 | |||
| A61K 45/06 | |||
| A61K 31/00 | |||
| G01N 33/68 | |||
| A61P 25/28 |
| (11) | Patento numeris | 3436010 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17719380.2 |
| Europos patento paraiškos padavimo data | 2017-03-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/024526 |
| Data | 2017-03-28 |
| (87) | Numeris | WO 2017/172757 |
| Data | 2017-10-05 |
| (30) | Numeris | Data | Šalis |
| 201662314857 P | 2016-03-29 | US | |
| 1630067 | 2016-04-04 | SE |
| (72) |
BURSTEIN, Ethan, US
|
| (73) |
Acadia Pharmaceuticals Inc.,
12830 El Camino Real, Suite 400, San Diego, CA 92130,
US
|
| (54) | 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES |
| 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES |